×
Back to Agenda
Develop Regulatory CMC Strategies to Mitigate Global Drug Shortages Risks for Marketed Drug Products
Session Chair(s)
Representative Invited
Mirum Pharmaceuticals, Inc., United States
Develop proactive Regulatory CMC strategies to mitigate and prevent drug shortage risks for marketed products
Learning Objective : Benchmark key drivers for assessing supply- and demand-related risks that may lead to drug shortages. Develop proactive Regulatory CMC strategies to mitigate and prevent drug shortage risks for marketed products. Apply risk-based decision making to strengthen global supply continuity and regulatory compliance.
Have an account?